Repurposing FDA-approved drugs against multiple proteins of SARS-CoV-2: An in silico study

Eitemau Tebyg

• Repurposing FDA-approved drugs as multi-stage antimalarials: An in silico investigation
  gan: Funmilayo I.D. Afolayan, et al.
  Cyhoeddwyd: (2026-01-01)
• Computational identification of potential inhibitors for dominant proteins in Viperidae snakes from FDA-approved drugs
  gan: Akindele Oluwatosin Adeyi, et al.
  Cyhoeddwyd: (2026-03-01)
• The repurposing of recently approved US-FDA drugs against Gram-negative bacteria's biofilm-forming proteins
  gan: Debanjan Dey, et al.
  Cyhoeddwyd: (2026-01-01)
• Repurposing FDA-Approved Drugs as Potential Inhibitors of MbtB for Tuberculosis Therapy
  gan: Soumi Chakraborty, et al.
  Cyhoeddwyd: (2025-11-01)
• Repurposing FDA approved drugs for psoriasis indications through integrated molecular docking, one-SVM algorithm, and molecular dynamics simulation approaches
  gan: Saumya Choudhary, et al.
  Cyhoeddwyd: (2025-07-01)